Randomized, placebo controlled clinical trial to evaluate the efficacy and safety of Phytolite plant sterol (95%) supplementation in the management of hypercholesterolemia. - Nil

Matrix fine Sciences Pvt Ltd0 sites90 target enrollmentTBD

Overview

No summary available.

Registry

who.int

Start Date

TBD

End Date

December 29, 2021

Last Updated

3 years ago

Study Type

Interventional

Sponsor

Matrix fine Sciences Pvt Ltd

•Male \& Female subjects aged between 30 to 60
•Dyslipidemia with any of the two parameters\-
•1\. Subjects with\- Total Cholesterol Ã¢â?°Â¥ 240 mg/dL, 2\. Triglycerides Ã¢â?°Â¥ 200 mg/dL
•3\. Subjects with high LDL in the range of 130\-220 mg/dL both inclusive
•Subjects with or without comorbidities but stable on a prescription
•Subjects with or without statin treatment

•Subjects with any acute illness requiring immediate medical care.
•Subjects who are contraindicated for statins/ phytosterols.
•Known subject with CRF and at critical stage at screening.
•Known subjects of hepatic failure/inflammation.
•Patients with uncontrolled diabetes and hypertension.
•Body mass index (BMI) \>40 kg/m2\.
•Subject proving to be unfit from investigators discretion.
•Pregnant and lactating women.
•Patients who participated in any clinical trial within 30 days before enrollment into the study.
•Subejcts in active infection phase for Covid 19\.